SCARPA, Sigfrido
 Distribuzione geografica
Continente #
NA - Nord America 2.893
EU - Europa 809
AS - Asia 426
SA - Sud America 19
AF - Africa 5
OC - Oceania 3
Totale 4.155
Nazione #
US - Stati Uniti d'America 2.871
SE - Svezia 261
IT - Italia 168
IN - India 163
SG - Singapore 159
UA - Ucraina 94
FI - Finlandia 91
CN - Cina 88
DE - Germania 80
GB - Regno Unito 23
RU - Federazione Russa 22
CA - Canada 21
AR - Argentina 19
IE - Irlanda 17
RO - Romania 15
BG - Bulgaria 10
NL - Olanda 10
IR - Iran 7
BE - Belgio 4
GR - Grecia 4
AU - Australia 3
ID - Indonesia 3
FR - Francia 2
JP - Giappone 2
TG - Togo 2
ZA - Sudafrica 2
BY - Bielorussia 1
CH - Svizzera 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
ES - Italia 1
KG - Kirghizistan 1
LU - Lussemburgo 1
MX - Messico 1
NO - Norvegia 1
PT - Portogallo 1
SA - Arabia Saudita 1
TM - Turkmenistan 1
TR - Turchia 1
Totale 4.155
Città #
Fairfield 439
Chandler 240
Woodbridge 216
Ashburn 192
Ann Arbor 185
Seattle 179
Houston 167
Cambridge 146
Wilmington 125
Singapore 110
Princeton 78
Plano 74
Rome 73
Boston 55
San Paolo di Civitate 51
Beijing 50
Fremont 47
Santa Clara 47
Lawrence 39
Jacksonville 35
Pune 32
Helsinki 26
Dearborn 24
Des Moines 23
San Diego 22
Andover 21
New York 21
Federal 19
Boardman 17
Dublin 15
Millbury 15
Falls Church 14
Norwalk 13
Grafing 11
Bremen 10
Dallas 10
Moscow 10
San Mateo 10
Sofia 10
Toronto 10
Bühl 8
Ottawa 7
Falkenstein 6
Mannheim 6
London 5
Munich 5
Shanghai 5
Brussels 4
Nanjing 4
Phoenix 4
Tappahannock 4
Ahmedabad 3
Catanzaro 3
Esslingen 3
Jakarta 3
Kunming 3
Leawood 3
Los Angeles 3
L’Aquila 3
Napoli 3
Sacramento 3
Shenyang 3
Southend 3
Zhangjiagang 3
Ancaster 2
Buffalo 2
Chicago 2
Durham 2
Genoa 2
Glasgow 2
Hefei 2
Jinan 2
Kobe 2
Langgöns 2
Lomé 2
Messina 2
Milan 2
Montréal 2
Philadelphia 2
Provo 2
San Francisco 2
Silverton 2
Timisoara 2
Tukwila 2
Venice 2
Zanjan 2
Zerbolò 2
Zhengzhou 2
Ashgabat 1
Athens 1
Atlanta 1
Baotou 1
Barcelona 1
Bishkek 1
Bologna 1
Cairo 1
Castlebar 1
Chengdu 1
Chongqing 1
Coominya 1
Totale 3.038
Nome #
Bioenergetic impairment in animal and cellular models of Alzheimer's disease: PARP-1 inhibition rescues metabolic dysfunctions 122
Disclosing bias in bisulfite assay: MethPrimers underestimate high DNA methylation. 98
DNA methylation profiles of selected pro-inflammatory cytokines in Alzheimer disease 95
GSK3β 5’-flanking DNA methylation and expression in Alzheimer’s disease patients 94
A reassessment of semiquantitative analytical procedures for DNA methylation: Comparison of bisulfite- and HpaII polymerase-chain-reaction-based methods 94
S-adenosylmethionine and superoxide dismutase 1 synergistically counteract Alzheimer's disease features progression in tgCRND8 mice 91
Cpg and non-Cpg presenilin1 methylation pattern in course of neurodevelopment and neurodegeneration is associated with gene expression in human and murine brain 91
Changes in myosin and myosin light chain kinase during myogenesis. 91
Photodynamic reactions in dimyristoyl L phosphatidylcholine (DMPC) liposomes 88
null 88
Role of S-adenosylmethionine in the modulation of oxidative stress-related neurodegeneration 87
S-adenosylmethionine and Superoxide-dismutase are effective in amyloidosis reduction in TgCRND8 mice. 86
Sertoli cells initiate testicular innate immune responses through TLR activation 83
Changes in Presenilin 1 gene methylation pattern in diet-induced B vitamin deficiency 82
Gene silencing through methylation: an epigenetic intervention on Alzheimer Disease 79
S-adenosylmethionine inhibits ubiquitin-proteasome system in vitro and on rat vascular smooth muscle cells 79
The expression of native and oxidized LDL receptors in brain microvessels is specifically enhanced by astrocytes-derived soluble factor(s) 78
Replacement of 5-methylcytosine by cytosine: a possible mechanism for transient DNA demethylation during differentiation. 76
Differentiation of myoblast cell lines and biological methylation: 3-Deazaadenosine stimulates formation of multinucleated myofibers 73
S-adenosylmethionine reduces the progress of the Alzheimer-like features induced by B-vitamin deficiency in mice 71
S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production 71
Autocrine production of basic fibroblast growth factor translated from novel synthesized mRNA mediates thrombin-induced mitogenesis in smooth muscle cells 71
Distribution of tissue-specific tightly bound non-histone proteins in the first level of repeating chromatin structures. 71
PARP-1 Modulates Amyloid Beta Peptide-Induced Neuronal Damage 69
Chromatin-Modifying Agents Increase Transcription of CYP46A1, a Key Player in Brain Cholesterol Elimination 69
One-Carbon Metabolism Alteration Affects Brain Proteome Profile in a Mouse Model of Alzheimer's Disease 69
PARP-1 inhibition decreases Beta-Amyloid-induced neurodegeneration: a cellular and animal model study 68
RAGE and LRP1 modulation in TgCRND8 mice under condition of B vitamin deficiency. 67
Methylation of genes related to Alzheimer Disease in neuroblastoma cells 66
One-carbon metabolism and Alzheimer's disease: is it all a methylation matter? 66
DNA methylase and demethylase activities are modulated by one-carbon metabolism in Alzheimer's disease models 65
PSEN1 promoter demethylation in hyperhomocysteinemic TgCRND8 mice is the culprit, not the consequence. 64
Urokinase expression in course of benign and malignant mammary lesions: comparison between nodular and healthy tissues 64
Vasopressin and insulin-like growth factors synergistically induce myogenesis in serum-free medium 60
S-Adenosylmethionine Prevents Oxidative Stress and Modulates Glutathione Metabolism in TgCRND8 Mice Fed a B-Vitamin Deficient Diet 60
Effects of different oxidizing agents on neutral amino acid transport systems in isolated bovine brain microvessels 59
B VITAMIN DEFICIENCY INVERSELY MODULATES RAGE AND LRP1 IN TGCRND8 MICE BRAIN 59
Proteomic analysis of TgCRND8 mice brain in condition of altered one-carbon metabolism. 59
Differential HLH family genes expression in L5 myoblasts by 3-deazaadenosine 58
S-adenosylmethionine and derivatives thereof for the treatment and prevention of Alzheimer Disease 55
Sexually dimorphic expression of reelin in a mouse model of Alzheimer disease 53
Evaluation of chemical and diastereoisomeric stability of S-adenosylmethionine in aqueous solution by capillary electrophoresis 53
γ-secretase is differentially modulated by alterations of Homocysteine cycle in neuroblastoma and glioblastoma cells. 52
B-Vitamin Deprivation Induces Hyperhomocysteinemia and Brain S-adenosylhomocsyteine, Depletes Brain S-adenosylmethionine, and Enhances PS1 and BACE Expression and Amyloid-β Deposition in Mice 52
Genotype, age and gender interaction in regulating BDNF expression in TgCRND8 Alzheimer's disease mice 51
PARP activation modulates apoptosis events in cellular and animal models of Alzheimer disease 50
B Vitamin Deficiency Promotes Tau Phosphorylation Through Regulation of GSK3 beta and PP2A 50
Erythroid differentiation and regulatory gene expression are modulated by adenosine derivatives interfering with S-adenosylmethionine metabolic pathway 49
Apoptotic events are modulated by poly(ADP-ribose)polymerase in cellular and animal models of Alzheimer disease 49
Analysis by two dimensional gel electrophoresis of developmentally regulated membrane proteins in L5/3C4 myoblast cell line 49
Expression of receptors for native and chemically modified low-density lipoproteins in brain microvessels 48
Collegamento telematico tra Dipartimento D’ Emergenza e Laboratorio per la trasmissione dei dati in urgenza 47
Simultaneous myogenin expression and overall DNA hypomethylation promote in vitro myoblast differentiation 47
Epigenetics and nutrition: B-vitamin deprivation and its impact on brain amyloid 47
The differentiation of LS/A10 myoblast cell line (a subclone of L5 line) is controlled by changes of cultural conditions 44
Exacerbation of Alzheimer-like features induced by B-vitamin deficiency is reversed by exogenous S-adenosylmethionine supplementation in TgCRND8 mice. 43
Presenilin 1 gene silencing by S-adenosylmethionine: a treatment for Alzheimer disease? 40
DIFFERENT LEVELS OF EXPRESSION, IN ENDOTHELIAL CELLS OF BRAIN MICROVESSELS AND AORTA vs VASCULAR SMOOTH MUSCLE CELLS, OF RECEPTORS FOR NATIVE AND MODIFIED LDL 39
Peritoneal lavage with gabexate-mesilate in ceruletide-induced acute pancreatitis in the rat 37
DNA methylation and CNS gene expression in AD models. 36
Complex expression of BDNF and reelin in the developing and adult brain of TgCRND8 mice 35
Efefct of one-carbon metabolism alteration on DNA methylation machinery in Alzheimer’s Disease models. . 33
GENE SILENCING BY S-ADENOSYLMETHIONINE IN MUSCLE DIFFERENTIATION 31
Nicotine regulates basic fibroblastic growth factor and transforming growth factor beta1 production in endothelial cells 30
Id1 expression during murine erythroleukemia cells differentiation is modulated by adenosine derivatives which affect s-adenosylmethionine metabolism 29
Early demethylation of non-CpG, CpC-rich, elements in the myogenin 5 '-flanking region A priming effect on the spreading of active demethylation? 29
Use of S-adenosylmethionine (SAM) and superoxide dismutase (SOD) for the preparation of medicaments for the treatment of Alzeimer's disease 28
The Dynamics of Myogenin Site-specific Demethylation is Strongly Correlated with its Expression and with Muscle Differentiation 28
The role of RNA Methylation in the Differentiation of L5 Myoblast Cell Line 25
Methylation Impairment and Alzheimer’s Disease. 25
The effect of S-adenosylmethionine on CNS gene expression studied by cDNA microarrays analysis 18
Totale 4.283
Categoria #
all - tutte 12.267
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 240
selected - selezionate 0
volume - volumi 0
Totale 12.507


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020550 0 0 0 0 0 101 108 105 88 67 52 29
2020/2021323 35 46 10 20 7 53 8 29 39 50 24 2
2021/2022832 1 52 62 48 103 19 15 83 48 59 194 148
2022/2023849 151 158 64 111 80 117 9 56 65 16 18 4
2023/2024358 24 56 9 20 23 84 6 34 0 34 38 30
2024/2025232 27 20 39 36 61 49 0 0 0 0 0 0
Totale 4.283